Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2010
03/25/2010US20100075944 Novel pyridine derivatives and pyrimidine derivatives (3)
03/25/2010US20100075942 N-phenyl-4-pyridin-2-yl-benzamide derivatives as histone deacylase (hdac) inhibitors for the treatment of cancer
03/25/2010US20100075934 5-lipoxygenase activating protein (flap) inhibitor
03/25/2010US20100075916 Substituted quinazoline inhibitors of growth factor receptor tyrosine kinases
03/25/2010US20100074867 P1-nonepimerizable ketoamide inhibitors of hcv ns3 protease
03/25/2010US20100072887 Organoselenium materials and their uses in organic light emitting devices
03/25/2010CA2770302A1 Small molecule compounds for stem cell differentiation
03/25/2010CA2737738A1 Heterocyclic carboxamide compounds
03/25/2010CA2737038A1 Amide compounds, compositions and uses thereof
03/25/2010CA2736955A1 Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
03/25/2010CA2734363A1 Substituted pyrrolidine-2-carboxamides
03/24/2010EP2166003A1 Excitatory amino acid receptor antagonists
03/24/2010EP2165709A2 Lysine based compounds
03/24/2010EP2165708A2 New pyrazole derivatives as transforming growth factor (tgf) inhibitors
03/24/2010EP2164843A1 Pyridazinone derivates
03/24/2010EP2164842A2 Thiazoles and pyrazoles useful as kinase inhibitors
03/24/2010EP2164840A2 Modulators of cftr
03/24/2010EP2164833A2 Quinazolinamide derivatives
03/24/2010EP2164832A1 Process for preparing 2-(2-pyridylmethyl)-sulfinyl-1h-benzimidazoles and the intermediate compounds used therein
03/24/2010EP2164326A1 Amide compounds and the use thereof
03/24/2010EP2089378B1 Short-acting benzodiazepine salts and their polymorphic forms
03/24/2010EP1644357B9 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
03/24/2010EP1615699B1 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
03/24/2010EP1560821B1 Antibacterial agents
03/24/2010EP1389110B1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/24/2010CN101679399A Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
03/24/2010CN101679378A Thiazoles and pyrazoles useful as kinase inhibitors
03/24/2010CN101679377A Heterocyclic hydrazide compound and pesticidal use of the same
03/24/2010CN101679376A fungicide heterocyclyl-pyrimidinyl-amino derivatives
03/24/2010CN101679375A 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators
03/24/2010CN101679374A Hydrazide compound and harmful arthropod-controlling agent containing the same
03/24/2010CN101679373A New solid forms of FXA inhibitors
03/24/2010CN101679372A Solid forms of a RAF kinase inhibitor
03/24/2010CN101679371A Substituted pyrimidines as adenosine receptor antagonists
03/24/2010CN101679370A Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals
03/24/2010CN101679369A Process for preparing bepotastine and intermediates used therein
03/24/2010CN101679368A aryloxazole, aryloxadiazole and benzimidazole derivatives
03/24/2010CN101679367A Therapeutic agent for cerebral infarction
03/24/2010CN101679366A pyridyl piperidine orexin receptor antagonists
03/24/2010CN101679365A Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application
03/24/2010CN101679364A heteroarylamide pyrimidone compounds
03/24/2010CN101679363A Novel pyrimidine compound having benzyl(heterocyclicmethyl)amine structure and pharmaceutical product containing the same
03/24/2010CN101679362A 4-{4-[({3-tert-butyl-1-[3-(hydroxymethyl) phenyl]-1h-pyrazol-5-yl } carbamoyl)-amino] -3-fluorophenoxy} -N-methylpyridine-2-carboxamide as well as prodrugs and salts thereof for the treatment of cance
03/24/2010CN101679361A Certain substituted amides, method of making, and method of use thereof
03/24/2010CN101679360A One-pot production process for cinnamide derivative
03/24/2010CN101679359A Quinolines and their therapeutic use
03/24/2010CN101679358A Pyrrole derivatives as p2y12 antagonists
03/24/2010CN101679357A Substituted heterocyclic derivatives and their pharmaceutical use and compositions
03/24/2010CN101679356A Novel crystalline forms of a vegf-r inhibitor
03/24/2010CN101679355A benzimidazole cannabinoid agonists
03/24/2010CN101679354A Novel triazinedione derivatives as GABAB receptor modulators
03/24/2010CN101679353A A new process for the manufacturing of the compound 2-hydroxy-3-[5-(morpholin-4-ylmethyl)pyridin-2-yl]1h-indole-5-carbonitrile 701
03/24/2010CN101679352A Process for producing pesticidal benzamide compounds
03/24/2010CN101679351A Quinoline compounds suitable for treating didorders that respond to modulation of the serotonin 5-ht6 receptor
03/24/2010CN101679350A Quinoline derivatives for the treatment of inflammatory diseases
03/24/2010CN101679349A 3-cyano-4-(4-phenyl-piperidin-1-yl)-pyridin-2-one derivatives
03/24/2010CN101679348A 5-pyridinone substituted indazoles
03/24/2010CN101679347A Fused amino pyridine as hsp90 inhibitors
03/24/2010CN101679319A Triazole compounds that modulate hsp90 activity
03/24/2010CN101679318A Development of molecular imaging probes for carbonic anhydrase-IX using click chemistry
03/24/2010CN101679310A Alkynylpyrimidines as Tie2 kinase inhibitors
03/24/2010CN101679308A inhibitors of the hedgehog pathway
03/24/2010CN101679306A Heteroarylamide pyrimidone derivatives
03/24/2010CN101679303A pyridazinone derivatives
03/24/2010CN101679301A Process for preparing 2-(2-pyridylmethyl)-sulfinyl-1h-benzimidazoles and the intermediate compounds used therein
03/24/2010CN101679299A Nicotinic acid derivatives as modulators of metabotropic glutamate receptor-5
03/24/2010CN101679291A Imidazolidine carboxamide derivatives as P2X7 modulators
03/24/2010CN101679287A nicotinic acetylcholine receptor modulators
03/24/2010CN101679283A Process for preparing 2-amino-5-cyanobenzoic acid derivatives
03/24/2010CN101679279A Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
03/24/2010CN101679277A Novel peptide inhibitors of hepatitis c virus replication
03/24/2010CN101679276A Isoquinolinone derivatives as nk3 antagonists
03/24/2010CN101679275A New compounds 707 and their uses
03/24/2010CN101679270A dihydroquinone and dihydronaphthridine inhibitors of jnk
03/24/2010CN101679266A PIM kinase inhibitors and methods of their use
03/24/2010CN101679264A inhibitors of focal adhesion kinase
03/24/2010CN101679262A Pyridone compound
03/24/2010CN101679261A Piperazine and piperidine mglur5 potentiators
03/24/2010CN101679260A 4,4-disubstituted piperidine derivatives
03/24/2010CN101679258A 4 -pi peridinylurea compounds as soluble epoxide hydrolase inhibitors
03/24/2010CN101679256A mono-hydrochloric salts of an inhibitor of histone deacetylase
03/24/2010CN101679255A Piperidinones useful in the treatment of inflammation
03/24/2010CN101679250A Ppar活性化合物 Ppar active compounds
03/24/2010CN101679249A Indole and benzothiophene compounds as modulators of the histamine h3 receptor
03/24/2010CN101679247A Process for the manufacture for non-steroidal anti-inflammatory agents and intermediates thereof
03/24/2010CN101679241A Prolinamide derivatives as NK3 antagonists
03/24/2010CN101679240A p1-nonepimerizable ketoamide inhibitors of hcv ns3 protease
03/24/2010CN101679239A inhibitors of histone deacetylase
03/24/2010CN101678330A Process for the production of palladium supported catalysts for catalyzing heck, suzuki-miyaura sonogashira coupling and buchwald-hartwig reactions
03/24/2010CN101678215A Sulfonyl amide derivatives for the treatment of abnormal cell growth
03/24/2010CN101678214A 芳基醚哒嗪酮衍生物 Aryl ether pyridazinones
03/24/2010CN101678129A Radioactive pet agents for imaging CCR5 in vivo
03/24/2010CN101678064A Methods of treating or preventing emesis using growth hormone secretagogues
03/24/2010CN101678020A Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of Janus kinases
03/24/2010CN101678011A Spiroindalones
03/24/2010CN101677554A Chemical compounds
03/24/2010CN101676283A preparation method of naratriptan
03/24/2010CN101676271A Tetracycline derivatives containing unsaturated heterocyclic amine
03/24/2010CN101676270A Novel imidazolidine derivative and use thereof
03/24/2010CN101676264A Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
1 ... 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 ... 1080